Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutogliptin Monotherapy in Type 2 Diabetes
NCT00690638Phase 3Completed
- Sponsor
- Phenomix Sciences
- Start
- Jul 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of dutogliptin in type 2 diabetes mellitus (T2DM), sponsored by Phenomix Sciences. Started Jul 2008; status: completed.
02
Drugs
dutogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00690638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690638.